We used integrated bioinformatics approaches to show that the expression of CD93 was closely related to the tumor stage and immune infiltration of pan-cancer and affected the prognosis of patients, so it has potential value to be a biomarker of prognosis. The gene discussed is CD93; the disease is cancer.